BECKY OPPER: Open Payments
NPI 1811263015 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,574 in 24 payments from 11 companies in 2025. Trend: 2023 $3,040 · 2024 $120 · 2025 $2,574
Food & beverage: $1,472Travel & lodging: $1,102
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $1,455 |
| Amgen Inc. | 2 | $255 |
| Janssen Biotech, Inc. | 4 | $168 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $136 |
| Procept Biorobotics Corporation | 1 | $125 |
| Edwards Lifesciences Corporation | 1 | $123 |
| GENZYME CORPORATION | 1 | $118 |
| Insulet Corporation | 1 | $114 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| COLOPLAST CORP | 1 | $20 |
Products named: Rezum Generator, PYLARIFY, KRYSTEXXA, AQUABEAM ROBOTIC SYSTEM, REPATHA, DUPIXENT, OMNIPOD, RYBREVANT.
Industry payments across FL — which companies pay providers there.
